| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | EVP, Ops &Strategy | Ex VP, Internal Operations +1 more
1 company
Donley Matthew Maxwell is a Chief Operating Officer at Aurinia Pharmaceuticals Inc.. Recent SEC Form 4 filings include 2 buys and 4 sells.
Estimated insider holdings value: $11.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | AUPH Aurinia Pharmaceuticals Inc. | Chief Operating Officer | Sell | 124,893 | $7.96 | $994,424.72 | -8.1% | -1.5% | +86.1% | |
| Mar 6, 2024 | AUPH Aurinia Pharmaceuticals Inc. | EVP, Ops &Strategy | Sell | 40,665 | $5.51 | $224,064.15 | -6.5% | -4.5% | +48.4% | |
| Nov 21, 2022 | AUPH Aurinia Pharmaceuticals Inc. | Ex VP, Internal Operations | Buy | 10,000 | $4.66 | $46,600.00 | +55.8% | +67.7% | +88.4% | |
| Mar 2, 2022 | AUPH Aurinia Pharmaceuticals Inc. | Ex VP, Intern'l Operations | Sell | 3,052 | $12.01 | $36,654.52 | -15.8% | -2.9% | -23.1% | |
| May 11, 2021 | AUPH Aurinia Pharmaceuticals Inc. | Ex VP, Intern'l Operations | Buy | 9,900 | $10.07 | $99,738.54 | New | +39.7% | -14.7% |